Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Cyclerion Therapeutics, Inc. - Common Stock (NQ:CYCN)

2.890 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 16,250
Open 2.890
Bid (Size) 3.010 (200)
Ask (Size) 3.090 (700)
Prev. Close 2.890
Today's Range 2.890 - 2.890
52wk Range 1.027 - 8.480
Shares Outstanding 43,524,894
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Halper Sadeh LLC is Investigating Whether SLNO, FORA, MKC, CYCN are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Monday's session: top gainers and losers ↗
Via Chartmill

Performance

YTD
+115.7%
+115.7%
1 Month
+94.0%
+94.0%
3 Month
+60.6%
+60.6%
6 Month
+14.7%
+14.7%
1 Year
+14.7%
+14.7%

More News

Read More
Monday's session: gap up and gap down stocks ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
Halper Sadeh LLC is Investigating Whether UNF, CYCN, NSA, ULYX are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Cyclerion Therapeutics, Inc. (Nasdaq – CYCN), National Storage Affiliates (NYSE - NSA), Urgent.ly, Inc. (OTC Markets - ULYX), UniFirst Corporation (NYSE - UNF)
From Brodsky & Smith LLC
Via GlobeNewswire
Unusual volume stocks in Thursday's session ↗
Via Chartmill
News headline image
CYCN Stock Alert: Halper Sadeh LLC is Investigating Whether Cyclerion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement
From Korsana Biosciences, Inc. and Cyclerion Therapeutics, Inc.
Via Business Wire
News headline image
Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board
From Cyclerion Therapeutics, Inc.
Via GlobeNewswire
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
Top movers analysis one hour before the close of the markets on 2026-01-06: top gainers and losers in today's session. ↗
Via Chartmill
Curious about the most active stocks on Tuesday? ↗
Via Chartmill
News headline image
FOCUSfactor® Beverage Emerges as a Growth Catalyst for Synergy CHC Corp. (NASDAQ: SNYR) – Alongside CYCN, ALMS, EVTV, RDZN See Why
Via AB Newswire
Unusual volume stocks are being observed in Tuesday's session. ↗
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
Traders are paying attention to the gapping stocks in Tuesday's session. ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression
From Cyclerion Therapeutics, Inc.
Via GlobeNewswire
News headline image
Wednesday's after hours session: top gainers and losers ↗
Via Chartmill
News headline image
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
News headline image
Get insights into the top gainers and losers of Tuesday's pre-market session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
These stocks are moving in today's after hours session ↗
Via Chartmill

Frequently Asked Questions

Is Cyclerion Therapeutics, Inc. - Common Stock publicly traded?
Yes, Cyclerion Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Cyclerion Therapeutics, Inc. - Common Stock trade on?
Cyclerion Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cyclerion Therapeutics, Inc. - Common Stock?
The ticker symbol for Cyclerion Therapeutics, Inc. - Common Stock is CYCN on the Nasdaq Stock Market
What is the current price of Cyclerion Therapeutics, Inc. - Common Stock?
The current price of Cyclerion Therapeutics, Inc. - Common Stock is 2.890
When was Cyclerion Therapeutics, Inc. - Common Stock last traded?
The last trade of Cyclerion Therapeutics, Inc. - Common Stock was at 04/08/26 04:00 PM ET
What is the market capitalization of Cyclerion Therapeutics, Inc. - Common Stock?
The market capitalization of Cyclerion Therapeutics, Inc. - Common Stock is 125.79M
How many shares of Cyclerion Therapeutics, Inc. - Common Stock are outstanding?
Cyclerion Therapeutics, Inc. - Common Stock has 126M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.